All In Biotech

Drug Trial Radar · NCT03589469

Study to Evaluate the Efficacy and Safety of Loncastuximab Tesirine in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

A Phase 2 Open-Label Single-Arm Study to Evaluate the Efficacy and Safety of Loncastuximab Tesirine in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) (LOTIS-2)

Last checked: Nov 20, 2026Latest source record: Aug 29, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

145

Actual

Start

Aug 1, 2018

Primary completion

May 24, 2020

Study completion Aug 9, 2022

Sponsor

Lead sponsor
ADC Therapeutics S.A.Industry
Sponsor type
Industry
First posted
Jul 18, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this Phase 2 study is to evaluate the clinical efficacy and safety of Loncastuximab Tesirine (ADCT-402) in patients with relapsed or refractory Diffuse Large B-Cell Lymphoma.

Conditions

  • Diffuse Large B-Cell Lymphoma Refractory
  • Diffuse Large B-cell Lymphoma Recurrent

Interventions

  • Loncastuximab tesirineDrug

    intravenous infusion

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Overall Response Rate (ORR)Time frame: Up to 21.5 months

Locations

37 sites in 4 countries. Site status is shown where the registry gives one.

  • City of Hope (City of Hope National Medical Center, City of Hope Medical Center)

    Duarte, California

  • Compassionate Care Research Group, Inc., at Compassionate Care Medical Group, Inc.

    Fountain Valley, California

  • UC San Diego Moores Cancer Center

    La Jolla, California

  • University of California, San Francisco Medical Center

    San Francisco, California

  • The Oncology Institute of Hope and Innovation

    Whittier, California

  • University of Miami Hospital and Clinics

    Miami, Florida

  • Miami Cancer Institute

    Miami, Florida

  • Winship Cancer Institute of Emory University

    Atlanta, Georgia

  • Northside Hospital

    Atlanta, Georgia

  • Northwest Georgia Oncology Centers, PC-Drug Shipment, Lab and Study Supplies Only

    Marietta, Georgia

  • Medical Oncology & Hematology Associates

    Des Moines, Iowa

  • Ochsner Clinic Foundation

    New Orleans, Louisiana

  • Washington University School of Medicine

    St Louis, Missouri

  • University of Nebraska Medical Center/ Nebraska Medicine

    Omaha, Nebraska

  • North Shore Hematology Oncology Associates DBA NY Cancer and Blood Specialists

    East Setauket, New York

  • University Hospitals Cleveland Medical Center

    Cleveland, Ohio

  • Sidney Kimmel Cancer Center at Thomas Jefferson University

    Philadelphia, Pennsylvania

  • Hollings Cancer Center

    Charleston, South Carolina

  • GHD Cancer Institute

    Greenville, South Carolina

  • Baylor University Medical Center

    Dallas, Texas

  • Baylor Scott & White Medical Center - Temple

    Temple, Texas

  • Virginia Cancer Specialists, PC

    Fairfax, Virginia

  • Vista Oncology Inc. PS

    Olympia, Washington

  • Froedtert Hospital & the Medical College of Wisconsin

    Milwaukee, Wisconsin

  • Dipartimento di Oncomatlolgia - Unita Linfomi

    Milan, Italy

  • Divisione di Oncoematologia

    Milan, Italy

  • A.O. SS Antonio e Biagio e Cesare Arrigo

    Alessandria, AL, Italy

  • Istituto di Ematologia Seragnoli

    Bologna, BO, Italy

  • U.O. Oncologia ed Ematologia

    Rozzano, Milano, Italy

  • Anastasios Stathis

    Bellinzona, Canton Ticino, Switzerland

  • Nottingham University Hospitals NHS Trust

    Nottingham, United Kingdom

  • University Hospitals of Leicester NHS Trust.

    Leicester, England, United Kingdom

  • University College London Hospital

    London, England, United Kingdom

  • The Christie NHS Foundation Trust

    Manchester, England, United Kingdom

  • Oxford Cancer Centre, Churchill Hospital

    Oxford, England, United Kingdom

  • NHS Greater Glasgow and Clyde

    Glasgow, Scotland, United Kingdom

  • Abertawe Bro Morgannwg University Health Board - Singleton Hospital

    Swansea, Wales, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.